TA Associates

TA Associates, founded in 1968, is one of the early modern-era private equity firms in the United States.[2] The firm leads buyouts and minority recapitalizations of profitable growth companies. TA Associates has invested across a range of industries, including technology, healthcare, consumer products, financial services and business services.

TA Associates Management, L.P.
TypeLimited Partnership
IndustryPrivate Equity
Founded1968 (1968)
FounderPeter Brooke
HeadquartersJohn Hancock Tower
Boston, Massachusetts, United States
Key people
Brian J. Conway, Chairman
ProductsGrowth capital, Leveraged buyouts, Recapitalizations
AUM$32.5 billion[1]
Number of employees
126 [1]
Websitewww.ta.com

TA Associates has raised $32.5 billion of capital since inception.[3] Since its founding, the firm has been a lead investor and director in more than 500 companies, and been ranked among the 50 largest private equity firms (ranked 41 in 2014) globally.[4]

The firm is headquartered in Boston, Massachusetts. As of January 1, 2015, TA had more than 130 employees, including 80 investment professionals in Boston, Menlo Park, London, Bengaluru, Mumbai and Hong Kong.

History

TA Associates was founded in 1968 by Peter Brooke with the backing of his former firm, Tucker, Anthony & RL Day, an investment banking and brokerage firm. Prior to founding TA, from 1963 to 1968, Brooke had headed the corporate finance and venture capital activities of Tucker Anthony. Previously, Brooke had been responsible for expanding the private equity activities of Bessemer Securities and had founded the High Technology Lending Group of First National Bank of Boston. At the time it was founded, the firm focused primarily on making venture capital investments in earlier stage companies.

The firm expanded significantly through the 1970s growing from $5 million of capital in 1969 to $125 million by the beginning of the 1980s, making TA the largest independent venture capital firm in a 1980 ranking.[5] Through the 1970s, the firm's investments averaged 30% to 40% annually. Among the firm's notable investments of the 1970s were Biogen, Artificial Intelligence Software, Immunogen and Digital Research.[5]

As the 1980s developed, TA found itself increasingly investing larger amounts in more mature, profitable companies as opposed to the small early stage investments in start-up companies that had characterized the firm's first decade and a half. By the mid-1980s, TA was no longer describing itself as a "venture capital firm", instead using the more general "private equity" description. By the early 1990s, the firm found itself rarely investing in early stage start-up companies, focusing primarily on later-stage growth capital investments in more mature businesses.[6]

Much of this evolution from a regional venture capital investor to global growth private equity firm has been credited to C. Kevin Landry.[7] Landry began his career with TA in 1968, became a General Partner in 1972, Managing Partner in 1982, CEO in 1984 upon the firm's incorporation, and Chairman in 2007. After retiring in 2012, he remained actively involved in the firm and was serving as a Senior Advisor at the time of his death in 2013.

In 2012, certain members of TA Associates leadership, independent of the firm, began financially supporting various conservative political action groups backing candidates in favor of repealing the Dodd–Frank Wall Street Reform and Consumer Protection Act publicly claiming it was "government regulation run amok."[8] Landry was among of the leading Super PAC donors to the 2012 Mitt Romney presidential campaign.[9] Landry told the Boston Globe the Dodd-Frank legislation costs TA more than $600,000 a year in compliance-related costs which would be better spent supporting job growth fueled by private equity firms such as Bain Capital and TA Associates.[10]

In 2014, TA Associates helped organize a syndicated loan worth $1.77 billion for Millennium Health LLC. Most of the loan – $1.27 billion – was channelled back to TA Associates and others, who used it to hand out special dividends.[11] Shortly thereafter, Millennium Health LLC declared bankruptcy.[12] Voya Investment Management, the creditor, subsequently, and unsuccessfully, filed a racketeering lawsuit against TA Associates and Millennium Health founder James Slattery.[13]

Spin-out firms

As one of the earliest venture capital firms, there are many successful investment firms that trace their lineage back to TA Associates.[14]

References
  1. "IAPD – Investment Adviser Public Disclosure – Homepage". adviserinfo.sec.gov.
  2. A Short (Sometimes Profitable) History of Private Equity, Wall Street Journal, January 17, 2012.
  3. "About TA".
  4. "Archived copy" (PDF). Archived from the original (PDF) on 2016-03-04. Retrieved 2016-01-31.CS1 maint: archived copy as title (link) [PEI 300, Top 50], Private Equity International, May 2014.
  5. Venture Capitalists' New Role. New York Times, August 31, 1981
  6. Gupta, Udayan. Done deals. 2000
  7. https://www.bloomberg.com/news/articles/2013-08-01/kevin-landry-former-ceo-of-ta-associates-dies-of-cancer-at-69
  8. Mitt Romney mum on how to regulate big banks, Boston Globe, May 2, 2012.
  9. Tea Party super PAC pours funds into congressional races, Boston Globe, June 6, 2012.
  10. Romney foes put Bain on defensive, Boston Globe, January 11, 2012.
  11. Beall, Pat (2016-01-12). "'The Big Wink:' How $1.8 billion loan boosted company's founder". The Palm Beach Post.
  12. Mazzucato, Mariana (2020). The Value of Everything. PublicAffairs. p. 146. ISBN 978-1541758247.
  13. Montgomery, Jeff (2018-09-24). "Del. Judge Backs Releases In Millennium Lab Holdings Ch. 11". Law360.
  14. "THE THRILL OF DEFEAT IN 1999". highbeam.com. 2001-02-05. Archived from the original on 2017-02-02. Retrieved 2017-01-25.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.